ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
MyoKardia Inc

MyoKardia Inc (MYOK)

224,91
0,00
(0,00%)
Geschlossen 22 November 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
224,91
Gebot
224,42
Fragen
224,91
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
224,91
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

MYOK Neueste Nachrichten

MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten

EXPLORER-HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Simultaneous Publication in Circulation Mavacamten Treatment Resulted in Favorable Effect on Cardiac Structure...

MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association’s Scientific Sessions 2020

ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients Markers of Physical Activity from...

MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertroph...

BRISBANE, Calif. and WASHINGTON, Nov. 11, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide...

MyoKardia Reports Third Quarter 2020 Financial Results

BRISBANE, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today reported financial results for the third quarter ended September 30, 2020. Recent Clinical Program...

MyoKardia Announces Awardees of the Second Annual MyoSeeds™ Research Grants Program

BRISBANE, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced three awardees of the 2020 MyoSeeds™ Research Grant Program, who have been selected to receive...

Bristol Myers Squibb and MyoKardia Announce Expiration of HSR Act Waiting Period

Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR...

MyoKardia Announces Multiple Abstracts Selected for Presentation at the Upcoming American Heart Association’s Annual Scient...

BRISBANE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced the upcoming presentation of clinical and non-clinical data related to mavacamten, MyoKardia’s...

Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash

Mavacamten Is a Potential First-in-Class Medicine with Compelling Data in the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Mavacamten Will Be a Medium- and...

MyoKardia Doses First Patient in Phase 2 Clinical Trial of Danicamtiv in Genetic Dilated Cardiomyopathy

BRISBANE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that the first patient has been dosed in the company’s Phase 2 clinical trial of danicamtiv...

MyoKardia to Participate in September Investor Conferences

BRISBANE, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced its participation in the following upcoming investor conferences: Citi’s 15th Annual...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WORXSCWorx Corporation
US$ 2,12
(116,33%)
143,48M
CRNCCerence Inc
US$ 5,83
(106,74%)
77,27M
PROCProcaps Group SA
US$ 1,10
(92,48%)
2,58M
IBGInnovation Beverage Group Limited
US$ 1,19
(50,40%)
12,97M
ARQQArqit Quantum Inc
US$ 10,7599
(46,59%)
891,32k
SKKSKK Holdings Limited
US$ 1,01
(-77,85%)
40,45M
TMTCTMT Acquisition Corporation
US$ 2,20
(-65,84%)
530,14k
WCTWellchange Holdings Company Limited
US$ 1,2596
(-62,06%)
2,34M
TMTCUTMT Acquisition Corporation
US$ 2,89
(-56,74%)
14,07k
GLXGGalaxy Payroll Group Ltd
US$ 1,77
(-54,73%)
2,45M
CDTConduit Pharmaceuticals Inc
US$ 0,1048
(13,54%)
573,38M
NVDANVIDIA Corporation
US$ 146,67
(0,53%)
387,95M
ELABElevai Labs Inc
US$ 0,020072
(-6,21%)
255,32M
AKTSAkoustis Technologies Inc
US$ 0,1022
(17,34%)
210,12M
MARAMARA Holdings Inc
US$ 24,19
(6,89%)
163,27M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock